WVE Return on Tangible Equity | WAVE LIFE SCIENCES LTD.

WAVE LIFE SCIENCES LTD. (WVE) Return on Tangible Equity

2026-06-30: Return Tang Equity -44.64%.
2026-03-31: Return Tang Equity -35.88%.
2025-12-31: Return Tang Equity -39.43%.
2025-09-30: Return Tang Equity -97.91%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-44.64%
2026-03-31	-35.88%
2025-12-31	-39.43%
2025-09-30	-97.91%
2025-06-30	-93.26%
2025-03-31	-65.38%
2024-12-31	-46.30%
2024-09-30	-100.62%
2024-06-30	2113.46%
2024-03-31	-242.88%
2023-12-31	-145.12%
2023-09-30	209.87%
2023-06-30	253.72%
2023-03-31	436.18%
2022-12-31	358.88%
2022-09-30	3383.47%
2022-06-30	-388.16%
2022-03-31	221877.36%
2021-12-31	-376.16%
2021-09-30	-388.78%
2021-06-30	-655.25%
2021-03-31	-274.29%
2020-12-31	-181.10%
2020-09-30	-164.35%
2020-06-30	4355.47%
2020-03-31	-944.15%
2019-12-31	-303.83%
2019-09-30	-152.26%
2019-06-30	-100.90%
2019-03-31	-79.05%
2018-12-31	-199.94%
2018-09-30	-130.91%
2018-06-30	-91.48%
2018-03-31	-105.52%
2017-12-31	-73.05%
2017-09-30	-54.20%
2017-06-30	-43.38%
2017-03-31	-58.85%
2016-12-31	-41.35%
2016-09-30	-29.14%
2016-06-30	-18.91%
2016-03-31	-16.09%
2015-12-31	-12.51%
2015-09-30	443.91%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-39.43%
2024-12-31	-46.30%
2023-12-31	-145.12%
2022-12-31	358.88%
2021-12-31	-376.16%
2020-12-31	-181.10%
2019-12-31	-303.83%
2018-12-31	-199.94%
2017-12-31	-73.05%
2016-12-31	-41.35%
2015-12-31	-12.51%
2014-12-31	-257.97%
2013-12-31	42.75%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78
GERON CORP (GERN)	United States	$0.803B	-12.14
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
COLLEGIUM PHARMACEUTICAL, INC (COLL)	United States	$0.737B	24.57
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44